Posted by admin on Aug 19th, 2022
RUA Life Sciences plc (LON:RUA – Get Rating)’s share price rose 6.7% during trading on Thursday . The stock traded as high as GBX 52.60 ($0.64) and last traded at GBX 48 ($0.58). Approximately 141,800 shares traded hands during mid-day trading, an increase of 165% from the average daily volume of 53,440 shares. The stock had previously closed at GBX 45 ($0.54).
Separately, Shore Capital reaffirmed a “suspended” rating on shares of RUA Life Sciences in a research report on Thursday, May 19th.
The company has a 50-day simple moving average of GBX 36.37 and a 200 day simple moving average of GBX 44.51. The company has a market cap of £10.65 million and a P/E ratio of -4.62. The company has a current ratio of 8.23, a quick ratio of 7.99 and a debt-to-equity ratio of 5.23.
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components.
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
Stock Traders Purchase Large Volume of Call Options on Curis (NASDAQ:CRIS)
Medigus (NASDAQ:MDGS) Trading 15.9% Higher